Hépato-Gastro & Oncologie Digestive
Agenda
Volume 30, supplement 4, September 2023
Non-colorectal oesogastric and MSI cancers: a story in perpetual motion!
Numéro réalisé avec le soutien institutionnel des laboratoires
Volume 30, supplement 4, September 2023
ÉDITORIAL
Oesogastric cancers and non-colorectal MSI cancers: immunotherapy goes from strength to strength
(p.5-6)
Astrid Lièvre
MINI-REVUES
Validated and promozing biomarkers in oesogastric cancers
(p.7-16)
Frédéric Bibeau, Franck Monnien, Maxime Laydi, Pierre Mathieu, Angélique Viennot, Julien Viot, Christophe Borg, Alexis Overs, Chloé Molimard
Immunotherapy in non-colorectal MSI tumors
(p.17-24)
Christelle de la Fouchardière
Towards integration of immune checkpoint inhibitors into clinical practice for advanced squamous cell oesophageal cancers
(p.25-30)
Antoine Adenis, Emmanuelle Samalin
Role of immunotherapy and new targeted therapies in the treatment of HER2-advanced œsophageal adenocarcinoma
(p.31-40)
Rosine Guimbaud, Nadim Farés